13F HOLDINGS REPORT
DAFNA Capital Management LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001389932-25-000004
Total Value
$393.4M
Positions
82
Other Managers
1
Confidential Omitted
No
Holdings (82)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P BIOTECH ETF | 78464A870 | 397,505 | $35.8M | 9.10% |
| 2 | STEREOTAXIS INC | STXS | 13,680,554 | $31.2M | 7.93% |
| 3 | REVOLUTION MEDICINES INC | RVMDW | 631,176 | $27.6M | 7.02% |
| 4 | ATRICURE INC | ATRC | 641,673 | $19.6M | 4.98% |
| 5 | MERUS N V | N5749R100 | 451,804 | $19.0M | 4.83% |
| 6 | CYTOKINETICS INC | CYTK | 398,100 | $18.7M | 4.76% |
| 7 | ASCENDIS PHARMA A/S | ASND | 103,355 | $14.2M | 3.62% |
| 8 | AXOGEN INC | AXGN | 846,882 | $14.0M | 3.55% |
| 9 | ISHARES NASDAQ BIOTECH INDX | 464287556 | 102,500 | $13.6M | 3.44% |
| 10 | BLUEPRINT MEDICINES CORP | 09627Y109 | 149,763 | $13.1M | 3.32% |
| 11 | IDEAYA BIOSCIENCES INC | IDYA | 498,827 | $12.8M | 3.26% |
| 12 | XENON PHARMACEUTICALS INC | XENE | 273,739 | $10.7M | 2.73% |
| 13 | NEUROCRINE BIOSCIENCES INC | NBIX | 71,615 | $9.8M | 2.48% |
| 14 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 731,363 | $9.3M | 2.36% |
| 15 | BIOHAVEN LTD | BHVN | 220,235 | $8.2M | 2.09% |
| 16 | TANDEM DIABETES CARE INC | TNDM | 223,208 | $8.0M | 2.04% |
| 17 | SYNDAX PHARMACEUTICALS INC | SNDX | 542,002 | $7.2M | 1.82% |
| 18 | KALVISTA PHARMACEUTICALS INC | KALV | 811,678 | $6.9M | 1.75% |
| 19 | UROGEN PHARMA LTD | URGN | 492,515 | $5.2M | 1.33% |
| 20 | DEXCOM INC | DXCM | 65,552 | $5.1M | 1.30% |
| 21 | BIOCRYST PHARMACEUTICALS INC | BCRX | 667,000 | $5.0M | 1.27% |
| 22 | EDGEWISE THERAPEUTICS INC | EWTX | 187,140 | $5.0M | 1.27% |
| 23 | ASCENDIS PHARMA A/S | ASND | 4,000,000 | $4.4M | 1.12% |
| 24 | TELA BIO INC | TELA | 1,441,029 | $4.4M | 1.11% |
| 25 | PROQR THERAPEUTICS N V | N71542109 | 1,567,561 | $4.2M | 1.06% |
| 26 | KURA ONCOLOGY INC | KURA | 448,368 | $3.9M | 0.99% |
| 27 | ARCUS BIOSCIENCES INC | RCUS | 254,217 | $3.8M | 0.96% |
| 28 | GALAPAGOS NV | GLPGF | 130,175 | $3.6M | 0.91% |
| 29 | ALKERMES PLC | ALKS | 120,700 | $3.5M | 0.88% |
| 30 | INSULET CORP | PODD | 12,400 | $3.2M | 0.82% |
| 31 | ASTRIA THERAPEUTICS INC | 04635X102 | 299,775 | $2.7M | 0.68% |
| 32 | IMMUNOVANT INC | IMVT | 107,996 | $2.7M | 0.68% |
| 33 | ALLOGENE THERAPEUTICS INC | ALLO | 1,240,118 | $2.6M | 0.67% |
| 34 | VIKING THERAPEUTICS INC | VKTX | 64,516 | $2.6M | 0.66% |
| 35 | LEXEO THERAPEUTICS INC | LXEO | 393,083 | $2.6M | 0.66% |
| 36 | ACCURAY INC | ARAY | 1,222,358 | $2.4M | 0.62% |
| 37 | KEROS THERAPEUTICS INC | KROS | 130,316 | $2.1M | 0.52% |
| 38 | INOGEN INC | INGN | 208,790 | $1.9M | 0.49% |
| 39 | STOKE THERAPEUTICS INC | STOK | 171,097 | $1.9M | 0.48% |
| 40 | BICARA THERAPEUTICS INC | BCAX | 105,500 | $1.8M | 0.47% |
| 41 | BRAINSWAY LTD | BRSYF | 193,208 | $1.8M | 0.46% |
| 42 | MINERALYS THERAPEUTICS INC | MLYS | 146,500 | $1.8M | 0.46% |
| 43 | IMMATICS NV | IMTX | 245,000 | $1.7M | 0.44% |
| 44 | ALECTOR INC | ALEC | 912,928 | $1.7M | 0.44% |
| 45 | CENTURY THERAPEUTICS INC | IPSC | 1,704,232 | $1.7M | 0.44% |
| 46 | BICYCLE THERAPEUTICS PLC | BCYC | 120,799 | $1.7M | 0.43% |
| 47 | ITEOS THERAPEUTICS INC | 46565G104 | 188,347 | $1.4M | 0.37% |
| 48 | LARIMAR THERAPEUTICS INC | LRMR | 371,434 | $1.4M | 0.37% |
| 49 | REGULUS THERAPEUTICS INC | 75915K309 | 875,200 | $1.4M | 0.35% |
| 50 | AUTOLUS THERAPEUTICS PLC | AUTL | 586,667 | $1.4M | 0.35% |
| 51 | GOSSAMER BIO INC | GOSS | 1,409,262 | $1.3M | 0.32% |
| 52 | 2SEVENTY BIO INC | 901384107 | 429,252 | $1.3M | 0.32% |
| 53 | LINEAGE CELL THERAPEUTICS IN | 53566P109 | 2,511,374 | $1.3M | 0.32% |
| 54 | NEUROGENE INC | NGNE | 51,500 | $1.2M | 0.30% |
| 55 | MEDIWOUND LTD | MDWD | 64,479 | $1.1M | 0.29% |
| 56 | ALIGN TECHNOLOGY INC | ALGN | 5,500 | $1.1M | 0.29% |
| 57 | BIONTECH SE | BNTX | 8,500 | $968,575 | 0.25% |
| 58 | STRUCTURE THERAPEUTICS INC | GPCR | 35,500 | $962,760 | 0.24% |
| 59 | ARS PHARMACEUTICALS INC | SPRY | 88,790 | $936,735 | 0.24% |
| 60 | COMPASS PATHWAYS PLC | CMPS | 243,210 | $919,334 | 0.23% |
| 61 | TAYSHA GENE THERAPIES INC | TSHA | 522,500 | $903,925 | 0.23% |
| 62 | POLYPID LTD | PYPD | 291,273 | $885,470 | 0.23% |
| 63 | FOGHORN THERAPEUTICS INC | FHTX | 186,717 | $881,304 | 0.22% |
| 64 | PALVELLA THERAPEUTICS INC | PVLA | 71,452 | $857,424 | 0.22% |
| 65 | SUTRO BIOPHARMA INC | STRO | 437,079 | $804,225 | 0.20% |
| 66 | CENTESSA PHARMACEUTICALS PLC | CNTA | 47,453 | $794,838 | 0.20% |
| 67 | VIR BIOTECHNOLOGY INC | VIR | 100,000 | $734,000 | 0.19% |
| 68 | COMPUGEN LTD | CGEN | 447,202 | $684,219 | 0.17% |
| 69 | ACRIVON THERAPEUTICS INC | ACRV | 112,414 | $676,732 | 0.17% |
| 70 | SAGE THERAPEUTICS INC | 78667J108 | 108,200 | $587,526 | 0.15% |
| 71 | ADICET BIO INC | ACET | 600,000 | $577,200 | 0.15% |
| 72 | MASIMO CORP | MASI | 3,000 | $495,900 | 0.13% |
| 73 | AQUESTIVE THERAPEUTICS INC | AQST | 127,000 | $452,120 | 0.11% |
| 74 | APREA THERAPEUTICS INC | APRE | 137,174 | $451,302 | 0.11% |
| 75 | ADC THERAPEUTICS SA | ADCT | 224,081 | $445,921 | 0.11% |
| 76 | PERSPECTIVE THERAPEUTICS INC | CATX | 130,169 | $415,239 | 0.11% |
| 77 | BLACK DIAMOND THERAPEUTICS I | BDTX | 140,000 | $299,600 | 0.08% |
| 78 | BIOMX INC | PHGE | 401,136 | $292,869 | 0.07% |
| 79 | ACELYRIN INC | 00445A100 | 87,989 | $276,285 | 0.07% |
| 80 | COMPASS THERAPEUTICS INC | CMPX | 158,394 | $229,671 | 0.06% |
| 81 | NEVRO CORP | 64157F103 | 38,000 | $141,360 | 0.04% |
| 82 | SPERO THERAPEUTICS INC | SPRO | 125,000 | $128,750 | 0.03% |